Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for methyl root_names_name in Any Name (approximate match)

Showing 1131 - 1140 of 34007 results

First page
Previous page
Next page
Next page

Omesdafexor

E05WEZ4XLE

Search for Structure

Status:

Investigational

Source:

INN:omesdafexor [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/E05WEZ4XLE

Class (Stereo):

CHEMICAL (ACHIRAL)

Apinocaltamide

3Z7U1U8Z9E

Search for Structure

Status:

Investigational

Source:

NCT03239691: Phase 2 Interventional Completed Photosensitive Epilepsy

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03239691

Class (Stereo):

CHEMICAL (ACHIRAL)

SENEXIN B

E2X758P2BZ

Search for Structure

Status:

Investigational

Source:

NCT03065010: Phase 1 Interventional Completed Breast Cancer

(2016)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03065010

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

Cell division cycle 2-like protein kinase 6

Conditions:

Senexin B is a selective CDK8/CDK19 inhibitor developed by Senex Biotechnology Inc. Senexin B is an ATP pocket binder, with very high target selectivity as indicated by kinome profiling. CDK8/19 inhibition produces chemopotentiating, chemopreventive and anti-metastatic effects in different types of cancer.

Izuforant

IZ2A6R2JAL

Search for Structure

Status:

Investigational

Source:

INN:izuforant [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/IZ2A6R2JAL

Class (Stereo):

CHEMICAL (ACHIRAL)

TBA-7371

R3T98GBE3C

Search for Structure

Status:

Investigational

Source:

NCT04176250: Phase 2 Interventional Completed Pulmonary Tuberculosis

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04176250

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase

ACLIMOSTAT

X150A3JK8R

Search for Structure

Status:

Investigational

Source:

NCT03254368: Phase 2 Interventional Completed Type 2 Diabetes Mellitus

(2017)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03254368

Class (Stereo):

CHEMICAL (ABSOLUTE)

BASIFUNGIN

VV0USO6I6U

Search for Structure

Status:

Investigational

Source:

INN:basifungin

Source URL:

https://tripod.nih.gov/npc/#Download

Class (Stereo):

CHEMICAL (ABSOLUTE)

Basifungin, previously known as LY 295337 or aureuobacidin A, is an antifungal agent that inhibits phosphorylceramide synthase. The development of basifungin against mycoses was discontinued.

Ilantimod

Y87V4WXQ4Z

Search for Structure

Status:

Investigational

Source:

INN:ilantimod [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/Y87V4WXQ4Z

Class (Stereo):

CHEMICAL (ABSOLUTE)

Nelutroctiv

9PN6C05CTD

Search for Structure

Status:

Investigational

Source:

INN:nelutroctiv [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/9PN6C05CTD

Class (Stereo):

CHEMICAL (ABSOLUTE)

RIMTUZALCAP

USO2D5J77R

Search for Structure

Status:

Investigational

Source:

NCT03688685: Phase 2 Interventional Completed Essential Tremor

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03688685

Class (Stereo):

CHEMICAL (ACHIRAL)

Structure of Omesdafexor

ACHIRAL

Structure of Apinocaltamide

ACHIRAL

Structure of SENEXIN B

ACHIRAL

Structure of Izuforant

ACHIRAL

Structure of TBA-7371

ACHIRAL

Structure of ACLIMOSTAT

ABSOLUTE

VV0USO6I6U
Not a public record

Structure of BASIFUNGIN

ABSOLUTE

Structure of Ilantimod

ABSOLUTE

Structure of Nelutroctiv

ABSOLUTE

Structure of RIMTUZALCAP

ACHIRAL

Showing 1131 - 1140 of 34007 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1